Su‐jin Rhee

543 total citations
41 papers, 371 citations indexed

About

Su‐jin Rhee is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Su‐jin Rhee has authored 41 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Su‐jin Rhee's work include Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Su‐jin Rhee is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). Su‐jin Rhee collaborates with scholars based in South Korea, United States and Puerto Rico. Su‐jin Rhee's co-authors include Kyung‐Sang Yu, In‐Jin Jang, SeungHwan Lee, Sungzoon Cho, Seokho Kang, SoJeong Yi, Jae‐Yong Chung, Pilsung Kang, Joo‐Youn Cho and Taehoon Ko and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Su‐jin Rhee

38 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su‐jin Rhee South Korea 13 72 65 63 54 54 41 371
Staffan Rosenborg Sweden 13 71 1.0× 53 0.8× 43 0.7× 75 1.4× 65 1.2× 24 449
Pajaree Chariyavilaskul Thailand 12 63 0.9× 40 0.6× 37 0.6× 66 1.2× 60 1.1× 53 424
Anna Wiela−Hojeńska Poland 12 113 1.6× 36 0.6× 66 1.0× 72 1.3× 44 0.8× 42 416
Cui Yi-min China 12 61 0.8× 46 0.7× 33 0.5× 47 0.9× 42 0.8× 36 405
Fabien Lamoureux France 14 85 1.2× 53 0.8× 98 1.6× 89 1.6× 81 1.5× 40 523
Johanna Strandell Sweden 9 80 1.1× 99 1.5× 27 0.4× 33 0.6× 96 1.8× 15 489
Hyun Young Jeong South Korea 7 33 0.5× 88 1.4× 25 0.4× 89 1.6× 80 1.5× 14 378
Jina Jung South Korea 12 53 0.7× 23 0.4× 22 0.3× 90 1.7× 53 1.0× 37 395
Xiaoxi Liu United States 14 96 1.3× 99 1.5× 61 1.0× 53 1.0× 55 1.0× 33 490
Supeecha Wittayalertpanya Thailand 11 68 0.9× 20 0.3× 36 0.6× 54 1.0× 69 1.3× 47 405

Countries citing papers authored by Su‐jin Rhee

Since Specialization
Citations

This map shows the geographic impact of Su‐jin Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐jin Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐jin Rhee more than expected).

Fields of papers citing papers by Su‐jin Rhee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐jin Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐jin Rhee. The network helps show where Su‐jin Rhee may publish in the future.

Co-authorship network of co-authors of Su‐jin Rhee

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐jin Rhee. A scholar is included among the top collaborators of Su‐jin Rhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐jin Rhee. Su‐jin Rhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rhee, Su‐jin, et al.. (2025). Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities. Clinical and Translational Science. 18(1). e70125–e70125. 1 indexed citations
4.
Kim, Yun, et al.. (2024). Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times. Drug Design Development and Therapy. Volume 18. 871–879. 1 indexed citations
6.
Lamichhane, Gopal, et al.. (2022). Anti-Obesity Potential of Ponciri Fructus: Effects of Extracts, Fractions and Compounds on Adipogenesis in 3T3-L1 Preadipocytes. Molecules. 27(3). 676–676. 12 indexed citations
7.
Lamichhane, Gopal, Jiao Luo, Xiaojun Li, et al.. (2022). Antiobesity Activity of Two Polyherbal Formulations in High‐Fat Diet‐Induced Obese C57BL/6J Mice. BioMed Research International. 2022(1). 9120259–9120259. 12 indexed citations
8.
Lamichhane, Gopal, et al.. (2021). 18KHT01, a Potent Anti-Obesity Polyherbal Formulation. Frontiers in Pharmacology. 12. 807081–807081. 17 indexed citations
9.
Kang, Gaeun, Kyung Hwa Park, Dong‐Gun Lee, et al.. (2020). Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea. Yonsei Medical Journal. 61(4). 301–301. 5 indexed citations
11.
Kim, Yun, Oliver Hatley, Su‐jin Rhee, et al.. (2019). Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation. Biopharmaceutics & Drug Disposition. 40(3-4). 135–150. 16 indexed citations
12.
Kim, Andrew HyoungJin, Bora Kim, Su‐jin Rhee, et al.. (2018). Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker. Drug Metabolism and Pharmacokinetics. 33(3). 173–178. 20 indexed citations
13.
Rhee, Su‐jin, et al.. (2018). Lack of a Clinically Significant Pharmacokinetic Interaction Between Pregabalin and Thioctic Acid in Healthy Volunteers. Clinical Therapeutics. 40(10). 1720–1728.e2. 5 indexed citations
14.
Rhee, Su‐jin, et al.. (2018). Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians. Drug Design Development and Therapy. Volume 12. 787–794. 4 indexed citations
15.
Chung, Hyewon, Kyung Taek Hong, Ji Won Lee, et al.. (2018). Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients. Bone Marrow Transplantation. 54(2). 284–292. 10 indexed citations
16.
Rhee, Su‐jin, Jung-Won Shin, SeungHwan Lee, et al.. (2017). Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy. Epilepsy Research. 132. 8–14. 30 indexed citations
17.
Yu, Kyung‐Sang, Su‐jin Rhee, Seung Hwan Lee, et al.. (2016). Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects. Drug Design Development and Therapy. 10. 1411–1411. 9 indexed citations
18.
Rhee, Su‐jin, et al.. (2015). Bioequivalence study of Donepezil hydrochloride in healthy Korean volunteers. Translational and Clinical Pharmacology. 23(1). 26–26. 4 indexed citations
19.
Rhee, Su‐jin, et al.. (2014). Abduction and Design Thinking - Theory and Practice of Creative Ideation -. 38. 7–35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026